[Current aspects of drug therapy of juvenile chronic arthritis].
From the sight of avoiding crippling and dying owing to juvenile chronic arthritis the importance of pharmacologic therapy is discussed. New opinions on the application of medicines already used are elaborated, new medicaments (piroxicam, sulfasalazin) are represented.
Klinik für Kinderheilkunde, Medizinischen Akademie Carl Gustav Carus, Dresden.
K
K
Lorenz
B
B
Tautz
J
J
Oppermann
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents
Aktuelle Aspekte der medikamentösen Therapie der juvenilen chronischen Arthritis (jcA).